Please note

Due to the recent spike in Covid-19 cases, we are no longer able to entertain walk-in visits to our headquarters or any of our facilities.

Gelafusal 4% IV infusion

Marketed by Dexa Medica

Ingredients in every 500 ml

Gelatin polysuccinate 20000 mg

Each package contains

1 bottle infusion of 500 ml

Dosage form

IV infusion

Dosage formIntravenous infusion

Flavour

None

W.H.O. classification

B05A
B05A

A.T.C. Level 1

Anatomical Main group

B - Blood and blood forming organs
B05A

A.T.C. Level 2

Therapeutic subgroup

B05 - Blood Substitutes and Perfusion Solutions
B05A

A.T.C. Level 3

Pharmacological subgroup

B05A - Blood and Related Products

Available in

Indonesia

Warnings

Alcohol

CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.

Machinery

SAFE IF PRESCRIBEDThis item is safe for use while operating heavy machinery.

Pregnancy

CAUTIONThis item may not be safe for use during pregnancy. Use with caution and after consultation with your doctor.

Lactation

CAUTIONThis item may not be safe for use during lactation. Use with caution and after consultation with your doctor.

Indication

As colloidal volume substitutes for prophylaxis and treatment of absolute and relative hypovolaemia (e.g. following shock due to haemorrhage of trauma, perioperative blood losses, burns, sepsis).

Dosage

18 YEARS OLD AND ABOVE
For intravenous use, the dosage and infusion rate are based on individual requirements and adapted to the patient's particular needs by monitoring the usual circulatory parameters. The following dosage recommendations are approximate.

— Small volume losses and stabilisation of the circulation before and during surgery:
500-1000 ml

— Larger volume losses, onset of shock:
1000-1500 ml

— Fully developed shock:
up to 2500 ml and more, depending on the volume loss

The maximum rate of infusion is dependent on the state of the cardiac circulation. The rate of administration can be increased by the application of pressure to the container or by use of a giving set pump. Gelafusal should be previously warmed to the body temperature if it is to be administered by pressure infusion (pressure cuff, infusion pump). Since the symptoms of shock are not apparent until a volume loss at least 1000 ml has occurred, a rapid infusion with positive pressure within 10-15 minutes is recommended in such cases.

In emergencies with circulatory collapse:
start with pressure infusion up to 500 ml; once the circulatory situation has improved, normal infusion depending on volume loss. In order to detect the occurrence of anaphylactoid/anaphylactic reactions as early as possible the first 20-30 ml should be infused slowly and under careful observation.

The therapeutic limit (maximum daily dose) is determined by dilution effects. The haematocrit regarded as critical for a particular patient should decided on an individual basis and should be guided by the clinical situation. It is essential to watch for any dilution of plasma proteins (including clotting factors) and to ensure that they are replaced as required. There is a risk of overloading the circulation if the infusion is given too quickly.

The duration of treatment is determined by the clinical situation.